The helmer breaks down his journey on the show, which may (or may not) have begun when he wrote to Reeves: "this was the ...

Local leaders expressed outrage Friday as news came out that Walgreens was preparing to close yet another store in the area, ...

I joined representatives from the Gandara Center and the Providers’ Council for the first-ever Western Massachusetts “Caring ...

Mississippi’s low labor force participation is a major issue, but one factor that’s often overlooked is how child care ...

In a recent letter, a writer makes a comment about a presidential candidate's statement about looks. Not one time did he ...

I have yet to figure out why I’m instructed by the (social and news) media not to discriminate against anyone based on their ...

At risk of sounding like an angry Boomer shaking his fist at the sky, I write to tell you of an epidemic here in Sioux City. No, it’s not a virus (although it is time to get your flu shot). This is an ...

NI GCSE results are far better compared to rest of UK,’ September 18). This time it is public examination outcomes. Dr ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

I know Trump loves America, I know in my heart of hearts he cares about all of us. Even though I don’t like Trump’s ...

津药药业表示，公司本次取得美国FDA签发的DMF FA Letter，表明FDA已完成对公司地夫可特原料药DMF文件的科学审查，可满足关联制剂客户的ANDA申报要求。地夫可特原料药此次通过技术审评，将对公司拓展美国市场、提升业绩带来积极影响。

财中社9月11日电 津药药业 （600488）发布公告称，公司近日收到美国食品药品监督管理局（FDA）签发的地夫可特原料药DMF First Adequate Letter（DMF FA Letter）。该药品为第三代糖皮质激素，主要用于治疗杜氏肌营养不良症（DMD），通过减轻炎症反应来帮助患者改善生活质量。